Investigation of Complications Following Port Insertion in a Cancer Patient Population: A Retrospective Analysis [0.03%]
癌症患者的输液港并发症回顾性分析调查研究
William Paul Skelton th,Aaron J Franke,Samantha Welniak et al.
William Paul Skelton th et al.
Central venous access devices, specifically implantable ports, play an essential role in the care of oncology patients; however, complications are prevalent. This retrospective single-institutional review was performed to identify rates of ...
Myoepithelial Cell Carcinoma of the Oral Tongue: Case Report and Review of the Literature [0.03%]
舌肌上皮细胞癌的病例报告及文献回顾
Robert G Nicholas,Josh A Hanson,Duncan A Meiklejohn
Robert G Nicholas
Background: Myoepithelial cell carcinoma is a rare malignant neoplasm of salivary gland origin that typically presents in the parotid gland and minor salivary glands. It has been described previously in head and neck site...
The Current Landscape of Treatment in Non-Metastatic Castration-Resistant Prostate Cancer [0.03%]
非转移性去势抵抗性前列腺癌的治疗现状
Joelle El-Amm,Jeanny B Aragon-Ching
Joelle El-Amm
Non-metastatic castration-resistant prostate cancer (nmCRPC) is a heterogeneous disease with variable potential in developing into overt metastases. It is an area of increased unmet need in advanced prostate cancer and for which there had b...
PAK1 Expression in Pancreatic Cancer: Clinicopathological Characteristics and Prognostic Significance [0.03%]
PAK1在胰腺癌中的表达及其临床病理特征和预后意义
Nikolaos Symeonidis,Maria Lambropoulou,Efstathios Pavlidis et al.
Nikolaos Symeonidis et al.
Background: Improvement of the management of pancreatic cancer requires a better understanding of the genetic and molecular changes responsible for the development of the disease. The family of p21-activated kinases (PAKs...
Access to Palliative Care for Cancer Patients Living in a Northern and Rural Environment in Ontario, Canada: The Effects of Geographic Region and Rurality on End-of-Life Care in a Population-Based Decedent Cancer Cohort [0.03%]
加拿大安大略省北部和农村地区癌症患者的姑息治疗的可及性：地理区域和农村性对人群基于死亡者的癌症队列生命末期护理的影响
Michael Sc Conlon,Joseph M Caswell,Stacey A Santi et al.
Michael Sc Conlon et al.
Background: Access to palliative care has been associated with improving quality of life and reducing the use of potentially aggressive end-of-life care. However, many challenges and barriers exist in providing palliative...
A Surgical Case of Inflammatory Myofibroblastic Tumor of the Liver: Potentially Characteristic Gross Features [0.03%]
肝脏炎性肌纤维母细胞瘤的手术病例报告——潜在的肉眼特征
Jiro Watanabe,Sohsuke Yamada,Yasuyuki Sasaguri et al.
Jiro Watanabe et al.
We herein reported a very rare surgical case of inflammatory myofibroblastic tumor (IMT) of the liver, showing potentially unique and specific gross findings on its cut surface: our IMT demonstrated a relatively well-demarcated and partly i...
Tumor Treating Fields for Glioblastoma Treatment: Patient Satisfaction and Compliance With the Second-Generation Optune® System [0.03%]
新型Optune®系统治疗胶质母细胞瘤患者满意度及依从性调查——肿瘤电场治疗(TTF)第二代设备临床应用效果观察研究
Adrian Kinzel,Michael Ambrogi,Michael Varshaver et al.
Adrian Kinzel et al.
Background: Tumor treating fields (TTFields) are a non-invasive antimitotic therapy that delivers alternating electric fields via the Optune® system. The Phase III EF-14 trial in newly diagnosed glioblastoma multiforme (...
Efficacy of Regorafenib in Metastatic Colorectal Cancer: A Multi-institutional Retrospective Study [0.03%]
雷戈菲尼片治疗转移性结直肠癌的疗效研究——多中心回顾性分析
Ali Aljubran,Mahmoud A Elshenawy,Magdy Kandil et al.
Ali Aljubran et al.
Background: Regorafenib is a multi-kinase inhibitor approved for treatment of refractory advanced colorectal cancer. It was found in the clinical trials to have a modest benefit and significant toxicity. Our aim was to as...
Hepatotoxicities Induced by Neoadjuvant Chemotherapy in Colorectal Cancer Liver Metastases: Distinguishing the True From the False [0.03%]
结直肠癌肝转移新辅助化疗所致的肝脏毒性：真毒副反应与假毒副反应的区别
Marie Desjardin,Benjamin Bonhomme,Brigitte Le Bail et al.
Marie Desjardin et al.
Background: Pre-operative chemotherapy for colorectal liver metastasis (CRLM) is thought to be the cause of hepatotoxicity of non-tumoural parenchyma. Studies on hepatotoxicity are contradictory. We investigated the impac...
The Nephroprotective Effect of Mannitol in Head and Neck Cancer Patients Receiving Cisplatin Therapy [0.03%]
甘露醇对头颈部癌症顺铂治疗患者的肾保护作用
Erik Hägerström,Lotte Lindberg,Jens Bentzen et al.
Erik Hägerström et al.
Introduction: Cisplatin is used as treatment for several different malignancies and a well-known complication is irreversible kidney damage. To protect the kidneys, this treatment is often combined with mannitol infusion ...